Robert H. Eckel

Endocrinology

1665 Aurora Ct Fl 2
Aurora, CO 80045

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 199 publications

Optimizing Care in Cardiovascular-Kidney-Metabolic Syndrome: Registry Data From the Cardiometabolic Center Alliance.

Optimizing Care in Cardiovascular-Kidney-Metabolic Syndrome: Registry Data From the Cardiometabolic Center Alliance.

Journal: Circulation. Population health and outcomes

Published: June 22, 2026

ApoE Lipidation State Directs Immunometabolic Reprogramming of Human Microglia.

ApoE Lipidation State Directs Immunometabolic Reprogramming of Human Microglia.

Journal: bioRxiv : the preprint server for biology

Published: May 18, 2026

SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.

SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.

Journal: Diabetes care

Published: May 04, 2026

Revisiting Insulin Resistance in the Pathophysiology of Type 2 Diabetes Mellitus: A Multi-Organ Perspective.

Revisiting Insulin Resistance in the Pathophysiology of Type 2 Diabetes Mellitus: A Multi-Organ Perspective.

Journal: Diabetes & metabolism journal

Published: May 04, 2026

Foods to Prevent Cardiometabolic Disease: Moving from "Saturated Fat" to "Whole Foods".

Foods to Prevent Cardiometabolic Disease: Moving from "Saturated Fat" to "Whole Foods".

Journal: Current developments in nutrition

Published: April 09, 2026

CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum.

CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum.

Journal: Cardiovascular diabetology

Published: January 26, 2026

Important Continuous Glucose Monitoring Attributes for Patients With Type 2 Diabetes.

Important Continuous Glucose Monitoring Attributes for Patients With Type 2 Diabetes.

Journal: Clinical diabetes : a publication of the American Diabetes Association

Published: December 24, 2025

Lipoprotein lipase requires a flexible lid and stable C-terminal, both maintained by ApoC-II peptide binding.

Lipoprotein lipase requires a flexible lid and stable C-terminal, both maintained by ApoC-II peptide binding.

Journal: bioRxiv : the preprint server for biology

Published: December 03, 2025

Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Gastroenterology

Published: September 18, 2025

Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Gastroenterology

Published: September 18, 2025

Improved cardiovascular outcomes with glucagon-like peptide-1 receptor agonists - what is the role of weight reduction?

Improved cardiovascular outcomes with glucagon-like peptide-1 receptor agonists - what is the role of weight reduction?

Journal: Cardiovascular endocrinology & metabolism

Published: September 01, 2025

Plain language summary about GLP-1 treatments in people with metabolic dysfunction-associated steatotic liver disease.

Plain language summary about GLP-1 treatments in people with metabolic dysfunction-associated steatotic liver disease.

Journal: Postgraduate medicine

Published: July 30, 2025

Showing 1-12 of 199

Last Updated: 09/26/2026